State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound.
Dr. Darien Sutton and Dr. Stephanie Widmer discuss new studies, which found GLP-1 weight loss drugs beneficial in fighting Type 2 diabetes and certain addiction disorders. Semaglutide, the ...
About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...